These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16219200)

  • 1. [Generic preparations].
    Ersgaard HV
    Ugeskr Laeger; 2005 Sep; 167(38):3609; author reply 3609-10. PubMed ID: 16219200
    [No Abstract]   [Full Text] [Related]  

  • 2. [Generics: authorization to market and quality guarantees].
    De Muylder JA
    Rev Med Brux; 2000 Sep; 21(4):A276-8. PubMed ID: 11068480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nevertheless control of documentation of generic drugs?].
    Halse J
    Tidsskr Nor Laegeforen; 2007 Jun; 127(12):1669. PubMed ID: 17571110
    [No Abstract]   [Full Text] [Related]  

  • 4. Medicines Shortages in the United Kingdom.
    Hughes DA
    Clin Pharmacol Ther; 2019 Oct; 106(4):712. PubMed ID: 31237353
    [No Abstract]   [Full Text] [Related]  

  • 5. EMEA tackles "generic" biologic drug issues.
    Rice M
    J Natl Cancer Inst; 2006 Apr; 98(7):435-6. PubMed ID: 16595776
    [No Abstract]   [Full Text] [Related]  

  • 6. Response to "Medicines Shortages in the United Kingdom".
    Breckenridge A; Feldschreiber P
    Clin Pharmacol Ther; 2019 Oct; 106(4):713. PubMed ID: 31237350
    [No Abstract]   [Full Text] [Related]  

  • 7. [The Medical Products Agency's preparations prior to the new EU regulation on children and drugs].
    Johannesson M; Berglund EG
    Lakartidningen; 2007 Jul 11-24; 104(28-29):2099. PubMed ID: 17702388
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug nomenclature: suggestions for change.
    Pollett HF
    CMAJ; 1992 Nov; 147(10):1422. PubMed ID: 1423079
    [No Abstract]   [Full Text] [Related]  

  • 9. In the name of safety.
    Parish C
    Nurs Stand; 2002 Oct 30-Nov 5; 17(7):12. PubMed ID: 12452078
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug nomenclature suggestions for change.
    Rutter P
    CMAJ; 1992 Nov; 147(10):1422. PubMed ID: 1423078
    [No Abstract]   [Full Text] [Related]  

  • 11. Fractured European market undermines biosimilar launches.
    Moran N
    Nat Biotechnol; 2008 Jan; 26(1):5-6. PubMed ID: 18183000
    [No Abstract]   [Full Text] [Related]  

  • 12. [Similarity of biotechnology-derived drugs: regulatory framework and specificity].
    Prugnaud JL
    Ann Pharm Fr; 2008 Aug; 66(4):206-11. PubMed ID: 18847566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sluggish generics entry prompts calls for European patent reform.
    Laursen L
    Nat Med; 2009 Nov; 15(11):1239. PubMed ID: 19893542
    [No Abstract]   [Full Text] [Related]  

  • 14. The end of the beginning?
    Nat Biotechnol; 2006 Apr; 24(4):367. PubMed ID: 16601702
    [No Abstract]   [Full Text] [Related]  

  • 15. [Greater control over drugs in the EEC].
    Sygeplejersken; 1994 Jan; 94(4):34. PubMed ID: 7940299
    [No Abstract]   [Full Text] [Related]  

  • 16. Path to approval proves rocky for copycat biodrugs.
    Wadman M
    Nature; 2005 Nov; 438(7065):154-5. PubMed ID: 16281004
    [No Abstract]   [Full Text] [Related]  

  • 17. Multi-level governance: The way forward for European illicit drug policy?
    Chatwin C
    Int J Drug Policy; 2007 Dec; 18(6):494-502. PubMed ID: 18061875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defeat of antipiracy treaty is hailed as victory for generic drugs.
    Moszynski P
    BMJ; 2012 Jul; 345():e4660. PubMed ID: 22777031
    [No Abstract]   [Full Text] [Related]  

  • 19. Brazil and India clash with EU over seizure of generic drugs.
    Zarocostas J
    BMJ; 2009 Feb; 338():b558. PubMed ID: 19208720
    [No Abstract]   [Full Text] [Related]  

  • 20. Current regulatory and legal considerations for follow-on biologics.
    Kingham RF; Lietzan E
    Clin Pharmacol Ther; 2008 Nov; 84(5):633-5. PubMed ID: 18716615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.